Assertio Therapeutics, Inc. (extinct)

Assertio Therapeutics, Inc. (extinct)

Assertio Therapeutics, Inc. (extinct)

Overview
Date Founded

2018

Headquarters

7999 Gateway Boulevard,Suite 300,Newark, CA 94560

Type of Company

Public

Employees (Worldwide)

501 - 1,000

Industries

Pharmaceuticals
Biotechnology
IT Consulting & Services
Medical Support Services

Company Description

Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.

Contact Data
Trying to get in touch with decision makers at Assertio Therapeutics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Paths to Assertio Therapeutics, Inc.
Potential Connections via
Relationship Science
You
Assertio Therapeutics, Inc.
Recent Transactions
Details Hidden

Assertio Therapeutics, Inc. purchases Zyla Life Sciences, Inc.

Details Hidden

Pamplona Capital Management LLP, CVC Advisers Ltd., Temasek Capital Pte Ltd., Alvogen, Inc., Vatera Healthcare Partners purchase Assertio Therapeutics, Inc. /Gralise Brand from Assertio Therapeutics, Inc.

Details Hidden

Assertio Therapeutics, Inc. purchases Janssen Pharmaceuticals, Inc. /Nucynta Franchise from Johnson & Johnson

Transaction Advisors
Accountant

Advised onBiovail Corp. purchases Assertio Therapeutics, Inc.

Legal Advisor

Advised onAssertio Therapeutics, Inc. purchases Janssen Pharmaceuticals, Inc. /Nucynta Franchise from Johnson & Johnson

Underwriter

Advised onAssertio Therapeutics, Inc. issued USD Common Stock

Legal Advisor

Advised onAssertio Therapeutics, Inc. purchases Janssen Pharmaceuticals, Inc. /Nucynta Franchise from Johnson & Johnson

Associate

Advised onAssertio Therapeutics, Inc. purchases Janssen Pharmaceuticals, Inc. /Nucynta Franchise from Johnson & Johnson

Legal Advisor

Advised onAssertio Therapeutics, Inc. purchases Janssen Pharmaceuticals, Inc. /Nucynta Franchise from Johnson & Johnson

Advisors & Consultants
Legal Advisor

Partner at Hogan & Lovells LLP

Legal Advisor

Co-Chair, Securities Regulation & Corporate Governance Practice Group at Gibson, Dunn & Crutcher LLP

Legal Advisor

US Chair, Life Sciences Patent Litigation Practice at DLA Piper

Key Stats and Financials As of
Market Capitalization
$40.3M
Total Enterprise Value
Earnings Per Share
Non-Profit Donations & Grants Received
Suppliers
Dow Chemical Company Agriculture & Mills | Midland, MI

The Dow Chemical Co. engages in the manufacture and distribution of chemicals, plastics, industrial and agricultural products. It serves agriculture, automotive, building and construction, consumer, electronic materials, infrastructure, packaging, product finder and product safety industries. The company was founded by Herbert Henry Dow in 1897 and is headquartered in Midland, MI.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Assertio Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Assertio Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Assertio Therapeutics, Inc..